Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>SLL>R/R> > TREAT.: > USA. V. Duvelisib Capsules

---

USA. V. Duvelisib Capsules's subsections
(*) USA Approval Date: 2018. 09.24.
>2 Prior Therapies
Company
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 2
Patent>UpDate: 2018. 09.18.
SLL: small lymphocytic lymphoma
TradeMark
TradeMark Web-Site

USA. V. Duvelisib Capsules's products
This section has no products